MP

Michel Perricaudet

AS Aventis Pharma S.A.: 16 patents #8 of 591Top 2%
RS Rhone-Poulenc Rorer S.A.: 9 patents #16 of 323Top 5%
CN CNRS: 7 patents #218 of 11,908Top 2%
IR Institut Gustave Roussy: 3 patents #27 of 201Top 15%
IP Institut Pasteur: 2 patents #407 of 1,210Top 35%
TS Transgene Sa: 2 patents #60 of 144Top 45%
GS Gencell, S.A.: 1 patents #4 of 20Top 20%
US US Dept of Health & Human Services: 1 patents #1,144 of 3,044Top 40%
UC University Of British Columbia: 1 patents #582 of 1,308Top 45%
📍 Rambouillet, FR: #2 of 271 inventorsTop 1%
Overall (All Time): #86,605 of 4,157,543Top 3%
38
Patents All Time

Issued Patents All Time

Showing 1–25 of 38 patents

Patent #TitleCo-InventorsDate
9862931 Adenovirus vaccine vectors Karim Benihoud, Anastasia Lanzi 2018-01-09
8642028 Recombinant adenoviruses encoding the specific iodine transporter (NIS) Martin SCHLUMBERGER, Patrice Yeh, Anne BOLAND-AUGE 2014-02-04
7306793 Defective recombinant adenoviruses expressing cytokines for antitumor treatment Hedi Haddada, Thierry Ragot 2007-12-11
7033826 Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses Martine Latta, Edouard Prost, Patrice Yeh, Cecile Orsini, Emmanuelle Vigne 2006-04-25
RE39078 Recombinant adenoviruses for gene therapy in cancers Jean-Francois Dedieu, Aude Le Roux 2006-04-25
6911199 Targeted adenovirus vectors for delivery of heterologous genes Emmanuelle Vigne, Jean-Francois Dedieu, Martine Latta, Patrice Yeh 2005-06-28
6814962 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same Patrick Benoit, Patrice Denefle, M. E. Suzanne Lewis, Michael Hayden 2004-11-09
6811774 Defective recombinant adenoviruses expressing cytokines for antitumor treatment Hedi Haddada, Thierry Ragot 2004-11-02
RE38556 Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias Patrick Benoit, Patrice Denefle, Sandrine Seguret, Emmanuelle Vigne 2004-07-13
6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain Axel Kahn, Gildas Le Gal La Salle, Jacques Mallet, Marc Peschanski, Jean-Jacques Robert 2004-06-29
6743623 Viral recombinant vectors for expression in muscle cells Pascale Briand, Leslie Stratford-Perricaudet 2004-06-01
6696420 Adenoviral vector with a deletion in the E1A coding region expressing a hetorologous protein Annick Ballay, Massimo Levredo, Pierre Tiollais 2004-02-24
6685934 Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF) Jacques Mallet, Emmanuelle Vigne, Frederic Revah, Marc Abitbol, Paul Roustan 2004-02-03
6669942 Defective adenoviruses including a therapeutic gene and an immunoprotectove gene Martin Jerome Lee 2003-12-30
6638502 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors Hong Li, He Lu, Frank Griscelli, Paule Opolon, Claudine Soria +5 more 2003-10-28
6630322 Generating replicating molecules in vivo Patrice Yeh, Hélène Leblois-Prehaud 2003-10-07
6489142 Methods and compositions for producing viral particles Christophe Torrent, Patrice Yeh, David Klatzmann, Jean-Loup Salzmann 2002-12-03
6482617 Viable contaminant particle free adenoviruses, their preparation and use Patrice Yeh, Cecile Orsini 2002-11-19
6475755 Adenoviral vectors for mutants of human interleukin 6 (hIL-6) with hIL-6 antagonist activity, pharmaceutical compositions therewith and their uses Gennaro Ciliberto, Isabella Saggio, Rocco Savino 2002-11-05
6464998 Composition for the in vivo production of therapeutic products Yves Beuzard, Olivier Danos, Vincent Descamps, Jean-Michel Heard, Philippe Moullier +2 more 2002-10-15
6458529 Assays for promoter operability in central nervous system cells Axel Kahn, Gildas Le Gal La Salle, Jacques Mallet, Marc Peschanski, Jean-Jacques Robert 2002-10-01
6426216 Defective recombinant adenovirus lacking E1A coding sequence and comprising a heterologous nucleotide sequence under control of the E1A promoter Annick Ballay, Massimo Levredo, Pierre Tiollais 2002-07-30
6420170 Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin Martine Latta, Edouard Prost, Patrice Yeh, Cecile Orsini, Emmanuelle Vigne 2002-07-16
6410011 Gene therapy for restenosis using an adenoviral vector Didier Branellec, Jean-Francois Dedieu, Patrice Denefle, Laurent Feldman, Philippe Gabriel Steg 2002-06-25
6387670 Method for producing recombinant virus Hélène Leblois-Prehaud, Emmanuelle Vigne, Patrice Yeh 2002-05-14